BACKGROUND: Knowledge of the exact numbers of patients suffering from chronic diseases, possibly requiring costly continuous treatment, is mandatory for future health care plans. Despite some regional biopsy registries, no valid data about the epidemiology of glomerulonephritis in Germany exist, because all publications are hampered by their retrospective character and lack of completeness. METHODS: In a unique cooperation of out-patient nephrologists with a single major teaching hospital serving a population of approx. 600,000 in the capital of Schwerin and surrounding counties, all patients with abnormal urine findings and/or decreasing renal function of unknown cause were referred for renal biopsy between October 2002 and December 2008. The drop-out rate is assumed to be less than 5%. All biopsies were analysed according to international standards and traditional epidemiological and clinical parameters were collected for comparison with the micro-census of Mecklenburg-Lower Pomerania region of the year 2008. We present the first valid estimations of incidence and 7 year prevalence of glomerulonephritis in Germany. RESULTS: In 222 patients, 251 renal biopsies were performed. The annual biopsy rate was 64 per million population (pmp; range 46.2-87.2). The incidence and prevalence of glomerulonephritis over 7 years was 52 and 285 pmp, respectively. The most frequent glomerulonephritis subtype was mesangioproliferative glomerulonephritis (20.9 pmp) followed by focal and segmental glomerulosclerosis (FSGS, 11.2 pmp) of which 43% had an etiologic underlying condition. The incidences of minimal change nephropathy (MCN), membranous nephropathy and necrotising glomerulonephritis (NGN) were 3.2, 5.2 and 4.9 pmp. In one third of all cases, the glomerulonephritis was secondary (incidence of secondary glomerulonephritis 17.5 pmp). Lupus nephritis and ANCA-associated glomerulonephritis were found in 2.9 and 5.4 cases pmp.
BACKGROUND: Knowledge of the exact numbers of patients suffering from chronic diseases, possibly requiring costly continuous treatment, is mandatory for future health care plans. Despite some regional biopsy registries, no valid data about the epidemiology of glomerulonephritis in Germany exist, because all publications are hampered by their retrospective character and lack of completeness. METHODS: In a unique cooperation of out-patient nephrologists with a single major teaching hospital serving a population of approx. 600,000 in the capital of Schwerin and surrounding counties, all patients with abnormal urine findings and/or decreasing renal function of unknown cause were referred for renal biopsy between October 2002 and December 2008. The drop-out rate is assumed to be less than 5%. All biopsies were analysed according to international standards and traditional epidemiological and clinical parameters were collected for comparison with the micro-census of Mecklenburg-Lower Pomerania region of the year 2008. We present the first valid estimations of incidence and 7 year prevalence of glomerulonephritis in Germany. RESULTS: In 222 patients, 251 renal biopsies were performed. The annual biopsy rate was 64 per million population (pmp; range 46.2-87.2). The incidence and prevalence of glomerulonephritis over 7 years was 52 and 285 pmp, respectively. The most frequent glomerulonephritis subtype was mesangioproliferative glomerulonephritis (20.9 pmp) followed by focal and segmental glomerulosclerosis (FSGS, 11.2 pmp) of which 43% had an etiologic underlying condition. The incidences of minimal change nephropathy (MCN), membranous nephropathy and necrotising glomerulonephritis (NGN) were 3.2, 5.2 and 4.9 pmp. In one third of all cases, the glomerulonephritis was secondary (incidence of secondary glomerulonephritis 17.5 pmp). Lupus nephritis and ANCA-associated glomerulonephritis were found in 2.9 and 5.4 cases pmp.
Authors: A S Levey; S Adler; A W Caggiula; B K England; T Greene; L G Hunsicker; J W Kusek; N L Rogers; P E Teschan Journal: Am J Kidney Dis Date: 1996-05 Impact factor: 8.860
Authors: Ivan Rychlík; Eva Jancová; Vladimír Tesar; Alexander Kolsky; Jirí Lácha; Josef Stejskal; Alena Stejskalová; Jirí Dusek; Vladimír Herout Journal: Nephrol Dial Transplant Date: 2004-10-26 Impact factor: 5.992
Authors: Loreto Gesualdo; Anna Maria Di Palma; Luigi Francesco Morrone; Giovanni Fabrizio Strippoli; Francesco Paolo Schena Journal: Kidney Int Date: 2004-09 Impact factor: 10.612
Authors: Savas Ozturk; Abdullah Sumnu; Nurhan Seyahi; Mustafa Gullulu; Murat Sipahioglu; Serra Artan; Zerrin Bicik; Sim Kutlay; Mustafa Keles; Deren Oygar; Ali Riza Odabas; Mansur Kayatas; Belda Dursun; Hayriye Sayarlioglu; Sinan Trablus; Dilek Guven Taymez; Ali Abbas Ozdemir; Gulizar Manga Sahin; Bulent Altun; Alper Azak; Lutfullah Altintepe; Gultekin Suleymanlar; Mehmet Koc; Yilmaz Selcuk; Rumeyza Kazancioglu; Reha Erkoc; Meltem Gursu; Mehmet Kucuk; Selma Alagoz Akcaoglu; Abdulmecid Yıldız; Aydin Unal; Ozger Akarsu; Kenan Ates; Erdem Cankaya; Aydin Turkmen Journal: Int Urol Nephrol Date: 2014-09-30 Impact factor: 2.370
Authors: Dita Maixnerova; Eva Jancova; Jelena Skibova; Romana Rysava; Ivan Rychlik; Ondrej Viklicky; Miroslav Merta; Alexander Kolsky; Jana Reiterova; Michaela Neprasova; Jana Kidorova; Eva Honsova; Vladimir Tesar Journal: J Nephrol Date: 2014-04-23 Impact factor: 3.902